Reduced antithrombin III and in-hospital organ failure in hypertriglyceridemia-associated acute pancreatitis with elevated D-dimer: a retrospective cohort study.
Wu Guotong G, Qiao Yulong Y, Pan Zhengyu Z, Wang Xin X et al.
D-dimer is widely used to reflect coagulation and fibrinolytic activation in acute pancreatitis, but outcomes vary among patients with elevated D-dimer. Reduced antithrombin III (AT-III) may indicate diminished endogenous anticoagulant reserve during systemic coagulation activation. We assessed the association between reduced AT-III and organ failure during hospitalization among patients with hypertriglyceridemia-associated acute pancreatitis (HTG-AP) and elevated D-dimer. This retrospective cohort study included hospitalized patients with HTG-AP from October 2020 to November 2025. D-dimer elevation was defined as > 0.55 mg/L FEU and AT-III reduction as < 75%, according to local laboratory reference ranges. The primary outcome was organ failure during hospitalization. Patients admitted in 2020-2023 and 2024-2025 were described as the earlier and later admission cohorts, respectively. Among patients with elevated D-dimer, binary logistic regression was used to evaluate the association between reduced AT-III and organ failure. The main model adjusted for age, sex, ln(D-dimer), ln(triglycerides), and ln(time from symptom onset to admission + 1). Of 959 patients with complete admission D-dimer and AT-III data, 79 (8.2%) had organ failure during hospitalization. Among 418 patients with elevated D-dimer, organ failure occurred in 44 of 151 patients (29.1%) with reduced AT-III and in 25 of 267 patients (9.4%) with preserved AT-III. After adjustment including continuous ln(D-dimer), reduced AT-III remained associated with organ failure (odds ratio [OR] 3.30, 95% confidence interval [CI] 1.86-5.85; P < 0.001). The corresponding observed event rates in the earlier and later admission cohorts were 27.8% and 31.5% with reduced AT-III, compared with 9.5% and 9.2% with preserved AT-III. Among patients with HTG-AP and elevated D-dimer, reduced AT-III was associated with a higher observed frequency of organ failure during hospitalization. These findings support further evaluation of AT-III as a routinely available coagulation marker in HTG-AP.